Resveratrol Mitigates Oxygen and Glucose Deprivation-Induced Inflammation, NLRP3 Inflammasome, and Oxidative Stress in 3D Neuronal Culture
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Oxygen glucose deprivation (OGD) can produce hypoxia-induced neurotoxicity and is a mature in vitro model of hypoxic cell damage. Activated AMP-activated protein kinase (AMPK) regulates a downstream pathway that substantially increases bioenergy production, which may be a key player in physiological energy and has also been shown to play a role in regulating neuroprotective processes. Resveratrol is an effective activator of AMPK, indicating that it may have therapeutic potential as a neuroprotective agent. However, the mechanism by which resveratrol achieves these beneficial effects in SH-SY5Y cells exposed to OGD-induced inflammation and oxidative stress in a 3D gelatin scaffold remains unclear. Therefore, in the present study, we investigated the effect of resveratrol in 3D gelatin scaffold cells to understand its neuroprotective effects on NF-κB signaling, NLRP3 inflammasome, and oxidative stress under OGD conditions. Here, we show that resveratrol improves the expression levels of cell viability, inflammatory cytokines (TNF-α, IL-1, and IL-18), NF-κB signaling, and NLRP3 inflammasome, that OGD increases. In addition, resveratrol rescued oxidative stress, nuclear factor-erythroid 2 related factor 2 (Nrf2), and Nrf2 downstream antioxidant target genes (e.g., SOD, Gpx GSH, catalase, and HO-1). Treatment with resveratrol can significantly normalize OGD-induced changes in SH-SY5Y cell inflammation, oxidative stress, and oxidative defense gene expression; however, these resveratrol protective effects are affected by AMPK antagonists (Compounds C) blocking. These findings improve our understanding of the mechanism of the AMPK-dependent protective effect of resveratrol under 3D OGD-induced inflammation and oxidative stress-mediated cerebral ischemic stroke conditions.
Chiang M, Yang Y, Nicol C, Chiang T, Yen C Life (Basel). 2025; 15(2).
PMID: 40003703 PMC: 11856727. DOI: 10.3390/life15020294.
Turovsky E, Plotnikov E, Varlamova E Biomedicines. 2024; 12(8).
PMID: 39200220 PMC: 11351740. DOI: 10.3390/biomedicines12081756.
Zhou C, Zhou Y, Vong C, Khan H, Cheang W J Cell Mol Med. 2024; 28(16):e70008.
PMID: 39153195 PMC: 11330235. DOI: 10.1111/jcmm.70008.
A comprehensive review on the neuroprotective potential of resveratrol in ischemic stroke.
Owjfard M, Rahimian Z, Karimi F, Borhani-Haghighi A, Mallahzadeh A Heliyon. 2024; 10(14):e34121.
PMID: 39082038 PMC: 11284444. DOI: 10.1016/j.heliyon.2024.e34121.
Gill J, Bansal B, Guo K, Huang F, Singh H, Hur J Int J Mol Sci. 2024; 25(11).
PMID: 38892421 PMC: 11173216. DOI: 10.3390/ijms25116235.